網頁平台症狀處理策略對活體肝臟捐贈者的長期症狀經驗與健康生活品質的影響:前瞻性臨床隨機試驗

注册号:

Registration number:

ChiCTR1900020518 

最近更新日期:

Date of Last Refreshed on:

2019-01-05 11:34:00 

注册时间:

Date of Registration:

2019-01-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

網頁平台症狀處理策略對活體肝臟捐贈者的長期症狀經驗與健康生活品質的影響:前瞻性臨床隨機試驗

Public title:

Web-based symptom management to improve long-term symptom experience and health-related quality of life for living liver donors: A prospective randomized controlled trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

網頁平台症狀處理策略對活體肝臟捐贈者的長期症狀經驗與健康生活品質的影響:前瞻性臨床隨機試驗

Scientific title:

Web-based symptom management to improve long-term symptom experience and health-related quality of life for living liver donors: A prospective randomized controlled trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

翁麗雀 

研究负责人:

翁麗雀 

Applicant:

Weng, Li-Chueh 

Study leader:

Weng, Li-Chueh 

申请注册联系人电话:

Applicant telephone:

+886 9 38595310

研究负责人电话:

Study leader's
telephone:

+886 9 38595310

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ax2488@mail.cgu.edu.tw

研究负责人电子邮件:

Study leader's E-mail:

ax2488@mail.cgu.edu.tw

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中國臺灣桃園市龜山區文化一路259號

研究负责人通讯地址:

中國臺灣桃園市龜山區文化一路259號

Applicant address:

259 First Wen-hwa Road, Kwei-Shan Township, Taoyaun, Taiwan, China

Study leader's address:

259 First Wen-hwa Road, Kwei-Shan Township, Taoyaun, Taiwan, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

長庚大學

Applicant's institution:

Chang Gung University

研究负责人所在单位:

長庚大學

Affiliation of the Leader:

Chang Gung University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

201701285B0

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

長庚醫療財團法人人體試驗倫理委員會

Name of the ethic committee:

Chang Gung Medical Foundation institutional Review Board

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

黃詩樺

Contact Name of the ethic committee:

Huang, Shih-Hua

伦理委员会联系地址:

桃園市龜山區舊路村頂湖路123號B2

Contact Address of the ethic committee:

B2F, 123 Dinghu Road, Guishan District, Taoyua, Taiwan, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+886 3 3196200-3712

伦理委员会联系人邮箱:

Contact email of the ethic committee:

shihhua@cgmh.org.tw

研究实施负责(组长)单位:

科技部

Primary sponsor:

Ministry of Science and Technology

研究实施负责(组长)单位地址:

中國臺灣臺北和平東路二段106號

Primary sponsor's address:

106 Second Section, Heping Road East, Taipei 10622, Taiwan, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中國

省(直辖市):

臺灣

市(区县):

Country:

China

Province:

Taiwan

City:

单位(医院):

長庚大學

具体地址:

臺灣桃園市龜山區文化一路259號

Institution
hospital:

Chang Gung University

Address:

259 First Wen-hwa Road, Kwei-Shan Township, Taoyaun, Taiwan, China

经费或物资来源:

科技部

Source(s) of funding:

Ministry of Science and Technology

研究疾病:

活體肝臟捐贈者  

Target disease:

living liver transplantation donor

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

卫生服务研究 

Study phase:

Health Services Research

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究以症狀處理理論(symptom management theory)為基礎,目的為探討網頁平台症狀處理策略對活體肝臟捐贈者在長期症狀經驗與健康生活品質的影響  

Objectives of Study:

The aim of this study is to test the effect of a web-based symptom management on long-term symptom experience and health-related quality of life of living liver donors.

药物成份或治疗方案详述:

以電腦輔助產生隨機碼將納入對象1:1分配為控制組與實驗組(預計樣本數共92人,每組46人)。控制組接受常規手術後衛教指導,實驗組除接受常規手術衛教指導並加上使用網頁平台症狀處理。此平台建置有研究者透過系統性文獻回顧方式所確認具有實證基礎的常見症狀處理及自我照顧指導的訊息以及電子版問卷,實驗組透過電子問卷與網頁平台串聯系統,獲得特定症狀處理的衛教指導訊息,此平台並具有溝通、警示的功能,使症狀處理更有效率。 

Description for medicine or protocol of treatment in detail:

Following completion of the baseline measures, participants will randomly (using computer assistant) with equal allocation (1:1) to experimental group and control group (total sample size 92, 46 in each group). Control group receive the usual instruction of post-surgery care. Participants in the experimental group receive the usual care plus web-based symptom management intervention. Participants complete the electronic questionnaire to identify their specific symptoms. These symptoms are the focus of the intervention. The information of symptom management and self-care will draw from the evidence-based of care guideline or study reports. The web-site also set communication and alert function in order to facilitate the efficacy of symptom management.  

纳入标准:

Inclusion criteria

排除标准:

排除條件為:手術後出現需重複住院處理的合併症(如:膽道問題)。

Exclusion criteria:

Donors who experience major surgical complication need hospitalization will be excluded.

研究实施时间:

Study execute time:

From 2019-01-11 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-01-11 00:00:00 To 2021-12-31 00:00:00

干预措施:

Interventions:

组别:

實驗組

样本量:

48

Group:

experimental group

Sample size:

干预措施:

網頁平台症狀處理

干预措施代码:

Intervention:

web-base symptom management

Intervention code:

组别:

對照組

样本量:

48

Group:

control group

Sample size:

干预措施:

常規衛教處理

干预措施代码:

Intervention:

usual care

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中國

省(直辖市):

臺灣 

市(区县):

Kwei-Shan Township 

Country:

China

Province:

Taiwan

City:

Kwei-Shan Township

单位(医院):

長庚大學 

单位级别:

大學 

Institution
hospital:

Chang Gung University

Level of the institution:

University

测量指标:

Outcomes:

指标中文名:

症狀困擾

指标类型:

主要指标

Outcome:

symptom distress

Type:

Primary indicator

测量时间点:

基礎值、每隔3個月

测量方法:

問卷量表

Measure time point of outcome:

baseline and 3 month interval

Measure method:

scale

指标中文名:

生活品質

指标类型:

主要指标

Outcome:

quality of life

Type:

Primary indicator

测量时间点:

基礎值及每3個月

测量方法:

問卷量表

Measure time point of outcome:

baseline and 3 months interval

Measure method:

scale

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

no

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由研究助理以電腦輔助產生隨機碼將納入對象1:1分配為控制組與實驗組(預計樣本數共92人,每組46人),隨機號碼放入隱密的信封。

Randomization Procedure (please state who generates the random number sequence and by what method):

participants will randomly (using computer assistant) with equal allocation (1:1) to experimental group and control group (total sample size 92, 46 in each group)by research assistants. The random results will protect in a conceal envelope.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

以文章發表

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Publication in manuscript

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

資料收集以網頁內建之電子表單收集,之後彙總報表以統計軟體管理,部分手術及疾病相關資料由紙本收集並妥善保管。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection is collected by electronic forms built into the webpage, and then the summary reports are collected by statistical software. Some surgical and disease-related data are collected and kept securely.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2019-01-05 11:34:00